September 20, 2022
  • McKesson Corp. announced it signed a definitive agreement to buy Rx Savings Solutions for up to $875 million. The company will pay $600 million upfront to the private pharmaceutical tech firm in a deal expected to close in the second half of fiscal 2023. McKesson Chief Executive Brian Tyler said the acquisition would bolster the drug distributor’s “ability to help solve the most common medication challenges related to access, affordability and adherence.” (Press release here; Article here)